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The chicken TVBS1 protein serves as the cellular receptor for the cytopathic subgroups B and D avian sarcoma and leukosis viruses
(ASLVs) as well as for the non-cytopathic subgroup E ASLV. Previous studies had mapped the subgroup B viral interaction determinants to a
region that was located between residues 32 and 46 of TVBS1 [J. Virol. 76 (2002) 5404]. To gain a greater insight into ASLV Env–receptor
interactions and the possible role of these interactions in viral cytopathic effects, we employed a homolog-scanning mutagenesis approach to
identify amino acid residues important for subgroup E viral receptor function by exchanging amino acid residues between TVBS1 and its
human homolog, DR5. These studies identified residues Tyr-67, Asn-72, and Asp-73 of TVBS1 as important subgroup E viral interaction
determinants. Intriguingly, these three residues are conserved between TVBS1 and DR5, demonstrating that the human protein contains
critical subgroup E viral interaction determinants, but in this context, they cannot support viral entry. These data confirm that the molecular
determinants of the TVB receptor required for subgroup E viral entry are completely distinct from those used by subgroup B viruses.
D 2003 Elsevier Inc. All rights reserved.Keywords: ASLV; Receptor; Cytopathic effect; TVB; DR5
TIntroduction
Retroviral infection is initiated through interactions be-
tween the viral envelope protein (Env) and specific host cell
surface receptors. Retroviral Env proteins are trimers of
heterodimers that are composed of a surface (SU) subunit
involved in receptor interaction as well as a transmembrane
(TM) subunit that is responsible for the fusion of virus and
cell membranes (Eckert and Kim, 2001).
We are using avian sarcoma and leukosis virus (ASLV)–
receptor interactions as a model system to study the mech-
anism of retroviral entry. ASLVs comprise the a retrovirus
family, and 10 major viral subgroups have been defined
(designated A through J) (reviewed in Hunter, 1997). Three
highly related TVB proteins (TVBS1, TVBS3, and TVBT)
function as cellular receptors for ASLV subgroups B, D, and
E. TVBS3 is a receptor for subgroups B and D viruses
(Brojatsch et al., 1996), TVBS1 is a receptor for subgroups0042-6822/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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E-mail address: jyoung@salk.edu (J.A.T. Young).B, D, and E viruses (Adkins et al., 2000), and TVB is a
receptor for subgroup E virus (Adkins et al., 1997). The
tvbs1 and tvbs3 genes are allelic variants of the same chicken
gene, whereas tvbt is the turkey homolog of this gene.
TVB proteins are tumor necrosis factor receptor (TNFR)-
related death receptors that most closely resemble the mam-
malian DR4 (TRAIL-R1) and DR5 (TRAIL-R2) receptors
for the TNF-related apoptosis-inducing ligand (TRAIL)
(Adkins et al., 2000, 2001; Brojatsch et al., 1996; MacFar-
lane et al., 1997; Pan et al., 1997). Like the TRAIL receptors,
TVB probably contains three extracellular TNFR-related
cysteine-rich domains (CRD1-3) that form an extended
structure characteristic of this protein family (Hymowitz et
al., 1999; Mongkolsapaya et al., 1999). TVB proteins also
contain a functional cytoplasmic death domain (Brojatsch et
al., 2000) that is postulated to activate caspase-dependent
apoptosis in cells via the formation of a death-inducing
signaling complex (DISC). The TRAIL-induced DISC con-
tains the adaptor protein TRADD, the death effector domain
containing protein FADD, and procaspases 8 and 10 (Bod-
mer et al., 2000; Griffith and Lynch, 1998; Kischkel et al.,
2000; Schneider-Schaulies et al., 2003; Sprick et al., 2000;
Tibbetts et al., 2003). Activation of these procaspases by
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caspases-3 and 9, leading ultimately to cell death by apo-
ptosis (Tibbetts et al., 2003).
The finding that TVB was a TRAIL receptor-like TNFR-
related death receptor was intriguing because previous
studies had suggested a possible linkage between Env–
TVB interactions and the cell death (cytopathic effect)
associated with massive rounds of viral superinfection of
cultured primary chicken cells infected by subgroups B and
D, but not subgroup E, ASLVs (Dorner and Coffin, 1986;
Weller and Temin, 1981; Weller et al., 1980). Therefore, the
hypothesis was formulated that subgroups B and D Env–
TVB interactions lead directly to cell death whereas sub-
group E Env–TVB interactions do not (Brojatsch, 1996).
Consistent with a role for TVB in stimulating viral-induced
cell death, mammalian TRAIL–receptor interactions also
contribute to apoptosis following infection by several other
viruses including human immunodeficiency viruses (HIV-1)
(Gougeon, 2003; Jeremias et al., 1998; Katsikis et al., 1997;
Miura et al., 2001, 2003; Yang et al., 2003; Zhang et al.,
2001), human T-cell leukemia virus-type 1 (HTLV-I) (Riv-
era-Walsh et al., 2001), reoviruses (Clarke and Tyler, 2003;
Clarke et al., 2003), respiratory syncytial virus (Kotelkin et
al., 2003), high-neurovirulence GDVII strain of Theiler’s
murine encephalomyelitis virus (Rubio et al., 2003), and
hepatitis B viruses (Janssen et al., 2003).
Although subgroup E viral infections are generally
considered to be non-cytopathic (Dorner and Coffin,
1986), quail QT-6 cells or turkey embryo fibroblasts
incubated with a soluble subgroup E-specific SU-immuno-
globulin fusion protein undergo extensive cell death in a
cycloheximide-dependent manner (Brojatsch et al., 2000).
As with other TNFR-related protein signaling pathways,
this cycloheximide dependence presumably reflects the
requirement for inactivating NF-nB-dependent cellular sur-
vival factors to observe TVB-activated cell death (Brojatsch
et al., 2000; Chi et al., 2002). Similar results were previ-
ously obtained with a soluble subgroup B-specific SU-
immunoglobulin fusion protein (Brojatsch et al., 1996).
Moreover, quail cells, engineered to express the TVBS3
receptor, that were chronically infected with either a
subgroup E or subgroup B-specific ASLV-E vector, were
also induced to die after cycloheximide treatment (Bro-
jatsch et al., 2000). Taken together, these studies revealed
that subgroup E-specific ASLV Env–receptor interactions
can lead to cell death at least when the expression of
putative cellular survival factors is extinguished. However,
these results do not exclude the possibility that subgroup-
specific differences in Env–receptor interactions contribute
to the differences in subgroups B, D, and E viral cytopath-
ogenicity when putative cellular survival factors are
expressed.
To better understand the molecular differences between
ASLV subgroups B and D and ASLV subgroup E interac-
tion with the TVB receptor, our laboratory has embarked
upon a series of studies aimed at defining amino acidresidues of TVB that are critical for binding subgroup B-
versus subgroup E-ASLV Env. The major ASLV-B interac-
tion site of TVB has already been identified within a N-
terminal 15 amino acid-long linear peptide (designated as
TVB32–46) that can serve as a minimal soluble receptor
(Knauss and Young, 2002). This peptide, corresponding to
residues 32–46 of the TVB receptor, binds specifically to
subgroup B ASLV Env, rendering receptor-deficient mam-
malian cells susceptible to infection by ASLV-B (Knauss
and Young, 2002). In addition, four residues in TVB32–46
(Leu-36, Gln-37, Leu-41, and Tyr-42) have been shown to
be important for subgroup B-specific viral receptor function
(Knauss and Young, 2002).
In sharp contrast to ASLV-B, the TVB determinants
required for ASLV-E entry appear to be conformation-
dependent, and it has been postulated that a disulfide bond
between the first two cysteines of TVB (Cys-46 and Cys-59)
is required (Adkins et al., 2001). In the present report, we
extend our knowledge of subgroup E ASLV Env–receptor
interactions and identify three amino acid residues of TVB
that are specifically required for ASLV-E receptor function.Results
The first two CRDs of TVBS1 are critical for subgroup E
virus receptor function
Previously, it was shown that a TVBS1 receptor lacking
CRD3 could support subgroup E viral entry (Adkins et al.,
2001). To examine the role of the CRD1 and CRD2 regions,
a homolog-scanning mutagenesis approach was employed
that involved exchanging specific subregions and amino
acid residues of the extracellular region of TVBS1 with those
of human DR5. DR5 does not support subgroup E viral
entry because it is expressed in HEK 293 cells (Shetty et al.,
2002) that are resistant to ASLV-E infection (Adkins et al.,
1997, 2000). The rationale for these studies is that we
hypothesized that one or more TVBS1-specific residues
would be critical for subgroup E viral receptor function.
To facilitate the mutagenesis studies, a synthetic TVB
gene containing multiple silent restriction enzyme sites was
constructed by PCR amplification using 16 overlapping
DNA oligonucleotides (Fig. 1A). The synthetic gene enc-
odes amino acid residues 1–186 of TVB (including the
signal peptide, extracellular domain, membrane-spanning
domain, and the first nine residues of the cytoplasmic tail)
fused to the enhanced green fluorescent protein (EGFP)
(Fig. 1A). The addition of EGFP allowed protein expression
to be monitored by flow cytometry without altering receptor
function (Adkins et al., 2000).
In the first set of six mutants tested, each of the three
extracellular CRDs of TVBS1 were either deleted or
replaced with the corresponding region from human DR5.
For those receptors that retained the subgroup B virus-
specific determinants located between residues 32 and 46
Fig. 1. A synthetic receptor gene was constructed as a template for mutagenesis. Panel A: The nucleotide and amino acid sequence of synthetic TVB. The
nucleotides that differ between the synthetic gene and the wild-type tvbS1 cDNA are indicated by capital letters. The restriction enzyme sites used to generate
deletions and for the insertion of double-stranded oligonucleotides to generate recombinant TVB/DR5 chimeric proteins are shown. The enhanced green
fluorescent protein, EGFP, was added to the cytoplasmic tail of the synthetic TVB receptor to facilitate the monitoring of protein expression. Panel B: Sequence
alignment of the cysteine-rich domain (CRD) 1 and 2 regions of TVBS1 and DR5. Conserved residues are indicated by shaded boxes and cysteines are
numbered individually.
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expression was confirmed by flow cytometric analysis using
a subgroup B-specific SU-immunoglobulin fusion protein
(SUB-rIgG) and an APC-conjugated secondary antibody.
For those altered receptors lacking the subgroup B-specific
virus determinants of TVBS1 (TD1, TD1), cell surface
expression was confirmed instead by biotinylating cell
surface proteins using the membrane-impermeable agent
Sulfo-NHS-LC-Biotin (Pierce). The biotinylated proteins
were then precipitated with streptavidin-conjugated agarose,
subjected to SDS-PAGE and transferred to a membrane, and
the altered TVB receptors were detected by immunoblotting
with a monoclonal antibody to EGFP and an HRP-conju-
gated secondary antibody. These analyses confirmed cell
surface expression of all six altered receptors (Figs. 2A, C).The altered receptors were then tested for their ability to
bind to subgroup E ASLV Env by performing flow cyto-
metric analysis with a subgroup E-specific ASLV SU-
immunoglobulin fusion protein (SUE-rIgG) and an APC-
conjugated secondary antibody (Fig. 2A). Concurrently,
receptors were tested for their abilities to support entry of
an ASLV-E Env pseudotyped murine leukemia virus (MLV)
vector encoding h-galactosidase (MLV-lacZ [EnvE]; Adkins
et al., 2000) (Fig. 2B). These studies confirmed that the
CRD3 of TVB is not essential for subgroup E viral receptor
function (Figs. 2A, B). These experiments also revealed that
each of the first two CRDs of TVBS1 are important for
subgroup E virus receptor function (Figs. 2A, B). Therefore,
it was concluded that certain TVBS1-specific amino acids,
located between residue 22 (the predicted N-terminal end of
Fig. 2. The first two cysteine-rich domains of TVBS1 are required for subgroup E virus entry. A schematic diagram of the receptors used is shown with the
TVBS1 sequence (open boxes with residues replaced indicated above each construct) and the DR5 sequence (shaded boxes with residues inserted below each
construct). SP: signal peptide; CRD: cysteine-rich domain; MSD: membrane-spanning domain. The different receptor constructs were expressed in transfected
HEK 293 cells, and 48 h later, the cells were tested for their abilities to bind to the subgroups B and E SU-immunoadhesins (SUB-rIgG and SUE-rIgG,
respectively) (panel A). A representative example of an experiment that was performed 3 times, each time with similar results, is shown. In panel B, the HEK
293 cells expressing altered receptors shown in panel A were challenged with MLV-lacZ [EnvE], a pseudotyped MLV vector with ASLV-E Env, and the h-
galactosidase gene (Adkins et al., 2000). Forty-eight hours after virus challenge, the cells were stained with X-gal and the blue colonies representing
independent infection events were counted. The result shown is a representative example of three experiments that were each performed in triplicate. Panel C:
Human 293 cells and transfected 293 cells expressing the TD1 and TD1 receptors were incubated with Sulfo-NHS-LC-Biotin (Pierce Chemicals), and
biotinylated cell surface proteins were precipitated with streptavidin-conjugated agarose and subjected to SDS-PAGE. The labeled receptor proteins were then
detected by immunoblotting with an EGFP-specific antibody followed by an HRP-conjugated secondary antibody.
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and residue 101 at the C-terminal end of CRD2, most likely
contribute to the subgroup E viral interaction.
Amino acid residues 22–45 of TVBS1 are not critical for
subgroup E viral receptor function
The amino acids located between residues 22 and 45
of TVBS1 are not conserved in DR5 (Fig. 1B). Toexamine if any of these residues contribute to ASLV-E
receptor function, this region of TVB was substituted with
the corresponding region of DR5. The altered receptor
(designated as DR-46-TVB) bound to SUE-rIgG and
supported the efficient entry of MLV-lacZ-[Env-E] into
transfected HEK 293 cells (Figs. 3A, B). Therefore, none
of the TVBS1-specific amino acid residues located N-
terminal to Cys-46 are critical for subgroup E viral
interaction.
Fig. 3. Subgroup E viral determinants are located between residues 63 and 77 of TVBS1. The altered receptors are depicted and were tested for subgroup E viral
receptor function, as described in the legend of Fig. 2. Representative examples of an experiment that was performed twice with similar results, and one that
was performed two independent times in triplicate, are shown in panels A and B, respectively.
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and 101 are not critical for ASLV-E receptor function
Eleven of the 25 amino acids located between residues
77 and 101 of TVB are not conserved in DR5 (Fig. 1B). To
establish whether any of these 11 residues are involved in
subgroup E viral receptor function, the TVB-77-DR recep-
tor was generated. This protein bound SUE-rIgG and
supported MLV-lacZ [EnvE] entry at levels that closely
approximated those seen with wild-type TVBS1 (Figs. 3A,
B). These data argue that none of the TVBS1-specific amino
acids located in this region of TVB are critical for subgroup
E viral receptor function.
Critical determinants of ASLV-E interaction map to the
region between residues 63 and 77 of TVBS1
The results described above suggested that TVBS1-spe-
cific determinants located between residues 46 and 77 likely
contribute to the ASLV-E interaction. To test the possible
involvement of TVBS1-specific amino acids at the C-termi-
nal end of CRD1, and at the N-terminal end of CRD2, the
TVB-68-DR, TVB-63-DR, and TVB-56-DR constructs
were generated (Fig. 3). These chimeric receptors were all
expressed at the cell surface as judged by SUB-rIgG binding
(Fig. 3A). However, all three constructs were defective in
binding SUE-rIgG and did not support entry of the subgroup
E-specific retroviral vector (Figs. 3A, B). As compared towild-type TVBS1, the level of viral entry seen with TVB-68-
DR was reduced by 2.2 logs (160-fold), whereas that seen
with TVB-63-DR and TVB-56-DR were 3.4 logs (3000-
fold) and 3.3 logs (1900-fold) reduced, respectively (Fig.
3B). These studies suggested that TVBS1-specific amino
acids located between residues 63 and 77 are important for
subgroup E viral interaction.
Residues Tyr-67, Asn-72, and Asp-63 of TVBS1 are
important for subgroup E virus entry
To identify critical amino acids within the residues 63–77
region of TVBS1 (Fig. 4A), an alanine-scanning approach
was adopted in which adjacent pairs of residues were
mutated to alanines. Binding of SUB-rIgG indicated that
all of these mutant receptor constructs were expressed on the
cell surface (Fig. 4B). The K63A/K64A, D65A/E66A,
E69A/Y70A, and Y70A/P71A mutant receptors were judged
to have approximately wild-type levels of subgroup E virus
receptor function as judged by SUE-rIgG binding and MLV-
lacZ[EnvE] entry (Figs. 4B, C). However, the N72A/D73A
mutant receptor was completely defective and the levels of
subgroup E viral entry obtained with the E66A/Y67A, and
Y67A/T68A mutant receptors were decreased by 1.7 logs
(50-fold) and 2.2 logs (165-fold), respectively, as compared
to wild-type TVBS1 (Fig. 4C). These data identified residues
Glu-66, Tyr-67, Thr-68, Asn-72, and Asp-73 as putative
subgroup E viral interaction determinants of TVBS1.
Fig. 4. Residues Tyr-67, Asn-72, and Asp-73 are important subgroup E viral interaction determinants of TVBS1. Panel A: An alignment of residues 62–77 of
TVBS1 with those of DR5. The altered receptors shown were tested for subgroup E viral receptor function as described in the legend to Fig. 2. Representative
examples of experiments that were performed twice with similar results, and those that were performed two independent times in triplicate, are shown in panels B
and D, and in panels C and E, respectively. The important residues Y67, N72, and D73 defined by these experiments are shown with shaded boxes in panel A.
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Fig. 5. DR5 residues 49–56 restore the function of the defective TVB-56-DR receptor. The TVB-49-DR receptor was generated representing the defective
TVB-56-DR receptor (Fig. 3) with residues 49–56 substituted with those of DR5. This receptor was tested for subgroup E viral receptor function as described
in the legend to Fig. 2. A representative example of an experiment that was performed twice with similar results, and one that was performed two independent
times in triplicate, are shown in panels A and B, respectively.
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ly, each was mutated singly to an alanine. As compared to
the wild-type receptor, the Y67A, N72A, and D73A muta-
tions each reduced SUE-rIgG binding (Fig. 4D) and led to
an approximately 10-fold decrease in MLV-lacZ [EnvE]
entry as compared to the wild-type receptor (Fig. 4E). By
contrast, the E66A and T68A mutations had little impact on
subgroup E viral receptor function (Figs. 4D, E). These
studies identified residues Tyr-67, Asn-72, and Asp-73 of
TVBS1 as ASLV-E interaction determinants.
A chimeric TVB receptor with residues 49–101 replaced
with those of DR5 functions as a subgroup E viral receptor
Remarkably, the three amino acid residues identified as
ASLV-E interaction determinants are conserved in DR5
(Fig. 4A). This finding suggested that DR5 does not lack
critical viral interaction determinants. Rather, these deter-
minants are present but cannot support viral interaction in
the context of the human protein. In strong support of this
notion, replacing residues 49–56 of the nonfunctional TVB-
56-DR receptor with those of DR5 led to a complete
restoration of receptor function (Figs. 5A, B). Therefore,
although DR5 is unable to support viral entry (Adkins et al.,
1997, 2000; Shetty et al., 2002), a segment derived from this
human protein is able to mediate subgroup E viral infection
when presented in the form of a chimeric TVB/DR5
receptor.Discussion
The goal of this study was to employ a homolog-
scanning mutagenesis approach to identify amino acid
residues of the TVB receptor that are critical for subgroup
E viral interaction. These studies identified residues Tyr-67,
Asn-72, and Asp-73 as being important. These require-
ments along with the putative disulfide bond betweencysteine residues 46 and 59 (Adkins et al., 2001) are
distinct from those (Leu-36, Gln-37, Leu-41, and Tyr-42)
shown previously to be important for subgroup B viral
receptor function (Knauss and Young, 2002). Thus, there is
a clear distinction between the interactions of the receptor
with ASLV-B and ASLV-E. The importance of residue Tyr-
67 is intriguing due to the fact that aromatic amino acid side
chains seem to play a role in other retroviral–receptor
interactions including those of receptors with HIV-1 and
HIV-2 (Moebius et al., 1992), ecotropic MLV (Malhotra et
al., 1996; Yoshimoto et al., 1993), ASLV-A (Zingler and
Young, 1996; Zingler et al., 1995), and ASLV-B (Knauss
and Young, 2002).
The independent mutations of residues Tyr-67, Asn-72,
and Asp-73 to alanines led only to an approximately 10-fold
decrease in subgroup E viral receptor activity, whereas pair-
wise alanine substitutions involving these residues had a
much greater inactivating effect (Fig. 4). These data are
consistent with other reports where multiple amino acid
substitutions are often required to completely inactivate
retroviral receptor function (Eiden et al., 1996; Lundorf et
al., 1999; Marin et al., 1999; Zingler et al., 1995).
There are several lines of evidence to suggest that DR5
contains a cryptic subgroup E Env interaction site. Firstly,
the critical subgroup E viral interaction determinants of
TVB, Tyr-67, Asn-72, and Asp-73 are completely con-
served in DR5. Secondly, the TD2 and TVB-49-DR chime-
ric receptors, containing the region of DR5 encompassing
these residues, had subgroup E viral receptor activity as
judged by their ability to support ASLV-E entry or to bind to
a subgroup E-specific SU-immunoglobulin fusion protein.
Thus, apparently, the primary reason for the failure of DR5
to support subgroup E viral entry is that the subgroup E viral
interaction determinants contained within this protein do not
support viral entry. This conclusion fits well with an
emerging hypothesis that retroviral receptor homologs from
species that are resistant to viral infection have evolved
under viral selection pressures to contain regulatory ele-
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interaction determinants (Tailor et al., 2003).
On the basis of inspection of the crystal structures of
TNFR-related proteins (TNFR1 and DR5) complexed with
ligands, we predict that the site of ASLV-E Env interaction
with TVB will most probably overlap with that of the TVB
ligand, which, although not yet identified, is most probably
chicken TRAIL. Lymphotoxin binding to TNFR1 and
TRAIL binding to DR5 each involve extensive contacts
in the CRD2 and CRD3 regions of the receptor (Banner et
al., 1993; Hymowitz et al., 1999; Mongkolsapaya et al.,
1999). Alignment of TVBS1 with DR5 indicates that the
analogous CRD2 ligand contact region in TVBS1 is located
between residues Tyr-67 and Cys-77, that is, the same
region that contains the critical subgroup E viral interaction
determinants. Once the TVB ligand has been identified, it
will be intriguing to establish whether its binding site does
overlap with that for ASLV-E Env. Moreover, it will be
important to establish whether the receptor (TVB)-interfer-
ence that is established following ASLV-E infection
(Adkins et al., 2001) can protect infected cells from
ligand-induced death: TRAIL appears to be an important
arm of the host antiviral response (Burgert et al., 2002;
Derfuss and Meinl, 2002; Kabsch and Alonso, 2002; Sato
et al., 2001; Tollefson et al., 2001) and it may be that
subgroup E viruses evolved to use TVB, at least in part, so
that the function of that receptor could be blocked by
interference, thus protecting the infected cell from ligand-
induced cell death. Future studies will define the role of the
TVB receptor in both ligand-induced and viral-induced
cell-killing events.Materials and methods
Cells and virus
Human embryonic kidney HEK 293 cells (obtained from
the ATCC) were maintained in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal calf serum. The
subgroup E-specific pseudotyped MLV-lacZ [EnvE] virus
was produced in the extracellular supernatant of transiently
transfected HEK 293 cells as described previously (Adkins
et al., 2000).
Construction and mutagenesis of a synthetic TVBS1 gene
A synthetic TVBS1 receptor gene was constructed by PCR
amplification using 16 double-stranded overlapping oligo-
nucleotides. The synthetic gene contained multiple intro-
duced restriction enzyme sites and encodes a protein with the
first 186 amino acids of TVBS1 fused to the enhanced green
fluorescent protein (EGFP). The mutant TVBS1 constructs
were generated either by deleting the intervening DNA
sequences between restriction enzyme sites in the synthetic
gene or instead by replacing these sequences with thosederived from DR5. The authenticity of the wild-type and
mutant receptor genes was validated by DNA sequencing.
All of the receptor constructs were subcloned between the
EcoR1 and Not1 restriction enzyme sites of the pLIB
expression vector (Clontech).
Transfections and infections
HEK 293 cells were transfected with plasmid vectors
encoding the different receptor constructs as described
previously (Adkins et al., 2000). Flow cytometric analysis
performed at 48-h post-transfection to detect EGFP attached
to the cytoplasmic tail of the receptor confirmed that the
transfection efficiencies were between 30% and 50% in all
experiments. At that time, the cells were challenged with
MLV-lacZ [EnvE] and the number of the resultant-infected
colonies was counted after X-gal staining as described
previously (Adkins et al., 2000).
SU-immunoadhesins and flow cytometry
The subgroup B-specific (SUB-rIgG) and subgroup E-
specific (SUE-rIgG) SU-rabbit immunoglobulin fusion pro-
teins were produced in the extracellular supernatant of
transiently transfected HEK 293 cells as described else-
where (Adkins et al., 2000). Flow cytometry was performed
48-h post-transfection with transfected HEK 293 cells
expressing the different receptor constructs and with the
SU-immunoglobulin fusion proteins and with a 1:400 dilu-
tion of an APC-conjugated goat anti-rabbit antibody as
described elsewhere (Adkins et al., 2000).
Biotinylation and Western blot
Approximately 2  106 transiently transfected HEK 293
cells were harvested in HEPES-buffered saline (HBS) con-
taining 1 mM EDTA and incubated with 0.5 mg/ml Sulfo-
NHS-LC-Biotin (Pierce) for 30 min at room temperature.
Cells were washed 3 times in HBS containing 20 mM
glycine, pelleted, and lysed in NP-40 lysis buffer (50 mM
Tris, pH 7.5, 150 mM NaCl, 1% NP-40). A 1-mg aliquot of
each sample was then incubated at 4 jC for 1 h with
streptavidin-conjugated agarose (Pierce) and then washed
5 times with NP-40 lysis buffer. The precipitated samples
were then subjected to SDS-PAGE under reducing condi-
tions using a 10% polyacrylamide gel, transferred to a
PDVF membrane, and immunoblotted with an anti-EGFP
monoclonal antibody (118P Covance) and anti-mouse HRP
secondary antibody.Acknowledgments
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